Agios’ mitapivat sNDA PDUFA goal date set for Feb. 1, 2027
The PDUFA goal date for Agios Pharmaceuticals’ mitapivat supplemental new drug application for sickle cell disease is Feb. 1, 2027.
The PDUFA goal date for Agios Pharmaceuticals’ mitapivat supplemental new drug application for sickle cell disease is Feb. 1, 2027.